Ascendis Pharma · 3 days ago
Director, Government Pricing (Managed Markets Finance) - Job ID: 1727
Princeton, NJ
Full-time
Onsite
Director/Executive
$215K/yr - $230K/yr
10+ years expAscendis Pharma is a dynamic, fast-growing global biopharmaceutical company advancing programs in Endocrinology Rare Disease and Oncology. The Director, Government Pricing will lead government pricing-related operations and reporting, ensuring compliance with federal and state pricing regulations while maximizing net revenue and supporting business planning.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Lead the end-to-end government pricing reporting and operations, including oversight of government pricing calculations, compliance, and reporting for programs such as AMP, BP, 340B/PHS, FSS/VA, ASP, NFAMP, FCP, IFF, and URA
Oversee the management of GP models, including calculation, validation, documentation, and submission of monthly, quarterly, and annual GP reports to CMS, VA/DoD, and state Medicaid agencies, and any programs requiring price reporting, per legislative requirements
Provide government pricing impact assessments to aid in the strategic direction on GTN modeling, forecasting, accruals, bid assessments, commercial contracting, new product launches, and scenario planning to inform financial planning and product pricing decisions
Partner cross-functionally with Commercial, Market Access, Trade, Global Finance, and Legal teams to ensure alignment and compliance
Guide the design and enhancement of automation tools and dashboards to streamline data aggregation, analytics, and executive reporting for government pricing
Serve as a key contributor in the assessment of new legislation (e.g., Inflation Reduction Act), including government pricing impact assessments
In partnership with Market Access, represent Government Pricing in strategic pricing committees, providing insight into the financial impact of pricing and contract decisions
Oversee the development and maintenance of SOPs, assumptions documentation, and procedural controls to ensure audit readiness and policy alignment and serve as SME for government pricing during audits and inquiries
Manage reviews and approvals of monthly accruals, reconciliations, utilization files (e.g., rebates, 340B claims), and reporting packages to ensure accuracy and compliance
Stay abreast of industry trends, policy changes, and regulatory updates; evaluate their potential impact on government pricing, GTN impact, pricing strategy, and financial forecasts
Serve as the primary point of contact for internal and external audits related to government pricing
Oversee vendors and consultants providing government pricing support or software solutions
Champion cross-functional initiatives related to FMV analysis, bona fide service fees, state transparency reporting, and other pricing-related special projects
Ensure compliance with laws governing government programs are within Ascendis’ written policies, procedures, and standards of conduct
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MHA, Finance, or related field) strongly preferred
Minimum 10+ years of progressive experience in pharmaceutical finance, pricing, market access, or government programs
Deep expertise in U.S. Federal and State Pricing Programs (Medicaid, Medicare, VA/DoD, PHS/340B) and related regulations
Expertise in GP reporting systems and tools (e.g., Revitas, ModelN, iCyte, Flex, etc.)
Strong command of GTN forecasting, accrual methodology, and related analytics and reporting
Prior experience interfacing with CMS, VA, and/or external auditors
Experience with product launches and lifecycle pricing strategy in heavily contracted therapeutic areas
Familiarity with Medicaid Supplemental Rebates and State Price Transparency Laws
Demonstrated ability to lead cross-functional initiatives and influence senior stakeholders
Proven ability to manage compliance risk in a dynamic and regulated environment
Exceptional analytical, problem-solving, and communication skills
High attention to detail, with a strategic mindset and ability to see the big picture
Benefits
401(k) plan with company match
Medical, dental, and vision plans
Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
Company-provided short and long-term disability benefits
Unique offerings of Pet Insurance and Legal Insurance
Employee Assistance Program
Employee Discounts
Professional Development
Health Saving Account (HSA)
Flexible Spending Accounts
Various incentive compensation plans
Accident, Critical Illness, and Hospital Indemnity Insurance
Mental Health resources
Paid leave benefits for new parents
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Ivanna Rosendal
Senior Director, IT Business Partner
Keren Tenenbaum
US General Counsel and Chief Compliance Officer
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase